Direct retroviral delivery of human cytochrome P450 2B6 for gene-directed enzyme prodrug therapy of cancer
- 1 July 2001
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 8 (7) , 473-482
- https://doi.org/10.1038/sj.cgt.7700329
Abstract
Human cytochrome P450 2B6 (CYP2B6) metabolizes the prodrug cyclophosphamide (CPA) to produce phosphoramide mustard that cross-links DNA leading to cell death. We have constructed a novel retroviral vector encoding CYP2B6 (designated “MetXia-P450”) and used it to transduce the human tumor cell lines HT29 and T47D. MetXia-P450 transduction sensitised these cells to the cytotoxic effects of the prodrug CPA. Results from in vitro experiments demonstrated adverse effects on the clonogenic survival of cyclophosphamide-treated cells transduced with MetXia-P450. Cytotoxic activity accompanied by bystander effect was particularly evident in 3-D multicellular spheroid models suggesting that this in vitro system may be a more appropriate model for assessing the efficacy of gene directed-enzyme prodrug therapy (GDEPT). We have applied this approach in a clinically relevant gene therapy protocol on established subcutaneous tumor xenografts. These studies show for the first time the efficacy of a P450-based GDEPT strategy mediated by a direct retroviral gene transfer in vivo. Cancer Gene Therapy (2001) 8, 473–482Keywords
This publication has 14 references indexed in Scilit:
- Cell-specific targeting of a thymidine kinase/ganciclovir gene therapy system using a recombinant sindbis virus vectorInternational Journal of Cancer, 1999
- Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450Gene Therapy, 1998
- An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapyNature Biotechnology, 1998
- Mustard Prodrugs for Activation by Escherichia coli Nitroreductase in Gene-Directed Enzyme Prodrug TherapyJournal of Medicinal Chemistry, 1997
- Nucleocytoplasmic transport: signals, mechanisms and regulationNature, 1997
- Expression of Co-Stimulatory Molecules by Tumor Cells Decreases Tumorigenicity but May Also Reduce Systemic Antitumor ImmunityHuman Gene Therapy, 1996
- A transient three-plasmid expression system for the production of high titer retroviral vectorsNucleic Acids Research, 1995
- Experimental Tumor Therapy in Mice Using the Cyclophosphamide-Activating Cytochrome P450 2B1 GeneHuman Gene Therapy, 1994
- Cell and Environment Interactions in Tumor Microregions: The Multicell Spheroid ModelScience, 1988
- Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system.Molecular and Cellular Biology, 1987